ARCHIVES

NCI CTEP-Approved Trials For the Month of March

This article is from The Cancer Letter archive.

Vol. 37 No. 3 | March 28, 2014

Download PDF Visit The Full Archive

Related Articles

Low Dose DFMO Reduces Colon Adenoma Recurrence

April 25, 2008

Workshop Suggests Confirmation of Vitamin C Studies

December 7, 1990

Palbocicilib Doubles PFS In Phase II Trial to 20.2 Months

April 25, 2014

“Too much [of NCI’s] planning is reactive rather than proactive. As a consequence, vision suffers.”

July 7, 1995

NCI Staff Suggest New Community Oncology, Pain Control, Nurse, Pathology Center Projects

May 13, 1977

Bristol-Myers Claims Settlements Are Close In Lawsuits Over Generic Taxol, BuSpar

January 10, 2003